A Case of Sunitinib-Induced Destructive Thyroiditis
Endocrinology and Metabolism
;
: 68-71, 2012.
Artigo
em Coreano
| WPRIM
| ID: wpr-107383
ABSTRACT
Sunitinib is a multi-targeted tyrosine-kinase inhibitor used for gastrointestinal stromal tumors and renal cell carcinoma (RCC). Several recent studies have reported sunitinib-induced hypothyroidism and thyroid dysfunction; however, the underlying mechanisms are not clear. Here, we report a patient with metastatic RCC, who developed destructive thyroidtis due to sunitinib treatment. The course followed in this case may be useful in understanding the clinical course of sunitinib-induced thyroiditis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pirróis
/
Glândula Tireoide
/
Tireoidite
/
Carcinoma de Células Renais
/
Tumores do Estroma Gastrointestinal
/
Hipotireoidismo
/
Indóis
Limite:
Humanos
Idioma:
Coreano
Revista:
Endocrinology and Metabolism
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS